High prolactin may protect against type 2 diabetes

• Univadis Medical News
• Monday 15 October 2018

The inverse association was observed in both premenopausal and postmenopausal women.

Multiple sclerosis: benefits of cannabinoids are limited

• Univadis Medical News
• Monday 15 October 2018

Findings from a new review and meta-analysis of trials including more than 3,000 patients.

New cancer vaccine shows promise for HER2-positive cancers

• Univadis Medical News
• Monday 15 October 2018

Based on the results and safety data, the US Federal Drug Administration has approved increasing the maximum dose and expanding the trial.

Does switching anti-psychotic medications improve outcomes in first-episode schizophrenia patients?

• 
• Monday 15 October 2018

The OPTIMISE trial was conducted in 14 European countries and Israel, in 27 centers

Can prenatal depression affect unborn babies?

• 
• Friday 12 October 2018

The researchers analysed a Norwegian sample of 22,195 mothers with 35,299 children

Global burden of firearm injury deaths

The study estimated firearm-related mortality from 1990-2016 for 195 countries and territories by age and by sex

Mild-to-moderate hypertension: does low-dose triple antihypertensive drug combination improve BP control vs usual care?

TRIUMPH: randomized open-label clinical trial among 700 hypertension patients enrolled from 11 urban hospital clinics in Sri Lanka

ASCO 2018 expert commentary: Many women won't benefit from chemo (TAILORx)

• Oncology Conference reports
• Monday 15 October 2018

Hear from a practicing breast oncologist what he thinks of the biggest story at ASCO—the TAILORx study.

WCLC 2018 — Advanced NSCLC: immuno-oncology less commonly used than expected

• Univadis
• Friday 28 September 2018

A retrospective analysis of 2700 patients.

WCLC 2018 — Lung cancer: aprepitant-based therapy quells CINV in Chinese study

• Univadis
• Friday 28 September 2018

Aprepitant with palonosetron and dexamethasone curbs chemotherapy-induced nausea, vomiting.